首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2019年 4期 肝纤维化/肝硬化的可逆性及评价 => 其他 =>炎症性肠病合并非酒精..
炎症性肠病合并非酒精性脂肪性肝病危险因素的Meta分析
Risk factors for the coexistence of inflammatory bowel disease and nonalcoholic fatty liver disease: A Meta-analysis
文章发布日期:2019年03月07日  来源:  作者:冯巩,贺娜,弥曼,等  点击次数:311次  下载次数:76次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的评估糖皮质激素、TNF药物、既往炎症性肠病(IBD)相关手术史是否为IBD合并非酒精性脂肪性肝病(NAFLD)的危险因素。方法通过检索Pubmed、Embase、the Cochrane library,以及万方、知网、维普数据库(检索时间跨度为建库至2018年10月),收集关于IBD合并NAFLD的危险因素的临床研究。根据纳入与排除标准,对纳入的文献进行总结和质量评价。采用Revman 5.2软件进行数据处理,异质性数据使用随机效应模型分析,同质性数据使用固定效应模型分析。结果共纳入7篇文献,共1645例患者。Meta分析结果表明,糖皮质激素不是IBD合并NAFLD的危险因素[比值比(OR)=1.19, 95%可信区间(95%CI): 0.90~1.57,P=0.23];抗TNF药物也不是IBD合并NAFLD的危险因素(OR=0.86, 95%CI:0.65~1.13,P=027);IBD相关手术史为IBD合并NAFLD的危险因素(OR=1.50,95%CI:1.09~2.05,P=0.01)。 结论糖皮质激素、抗TNF药物治疗IBD不是导致NAFLD发生的危险因素,IBD相关手术可能是导致NAFLD发生的危险因素。
【Abstract】:ObjectiveTo investigate whether glucocorticoids, anti-tumor necrosis factor (anti-TNF) drugs, and a past history of surgical treatment of inflammatory bowel disease (IBD) are the risk factors for the coexistence of IBD and nonalcoholic fatty liver disease (NAFLD). MethodsPubMed, Embase, Cochrane Library, Wanfang Data, CNKI, and VIP were searched for clinical trials of the coexistence of IBD and NAFLD published up to October 2018. The articles included were summarized and quality assessment was performed according to inclusion and exclusion criteria. RevMan 5.2 was used for data processing; the random effects model was used for data with heterogeneity, and the fixed effect model was used for data with homogeneity. ResultsA total of 7 articles were included, with 1645 patients. The meta-analysis showed that glucocorticoids might not be a risk factor for the coexistence of IBD and NAFLD (odds ratio (OR)=1.19, 95% confidence interval (CI): 0.90-1.57, P=0.23); anti-TNF drugs were not a risk factor for the coexistence of IBD and NAFLD (OR = 0.86, 95%CI: 0.65-1.13, P=0.27); a past history of surgical treatment of IBD was a risk factor for the coexistence of IBD and NAFLD (OR=1.50, 95%CI: 1.09-2.05, P=0.01). ConclusionGlucocorticoids and anti-TNF drugs for the treatment of IBD may not increase the incidence rate of the coexistence of IBD and NAFLD, while surgical treatment for IBD may increase this incidence rate.
【关键字】:炎性肠疾病; 非酒精性脂肪性肝病; 危险因素; Meta分析
【Key words】:inflammatory bowel diseases; nonalcoholic fatty liver disease; risk factors; Meta-analysis
【引证本文】:FENG G, HE N, MI M, et al. Risk factors for the coexistence of inflammatory bowel disease and nonalcoholic fatty liver disease: A Meta-analysis[J]. J Clin Hepatol, 2019, 35(4): 835-839. (in Chinese)
冯巩, 贺娜, 弥曼, 等. 炎症性肠病合并非酒精性脂肪性肝病危险因素的Meta分析[J]. 临床肝胆病杂志, 2019, 35(4): 835-839.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号